{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

Study Group Offers Insights on the Conflicting Signals within Copper Markets

May 8, 2026Following January’s surge to record highs, copper prices have entered a more cautious phase, reacting closely to developments surrounding the Iran crisis. The ongoing closure of the Strait of Hormuz presents a paradox for the market, creating both upward and downward pressure on prices.


GreenEnergyBreaks — American Fusion Inc. (OTC: AMFN) Advances 5MW Texatron Pre-Production Unit Toward Testing

May 8, 2026American Fusion (OTC: AMFN) reported that fabrication partners in Odessa, Texas, have completed the structural frame for the company’s 5MW Texatron(TM) pre-production unit, marking a key engineering milestone as the fusion energy developer moves from prototype development toward integrated system assembly and controlled testing. The unit is undergoing additional integration work before shipment to American Fusion’s Fort Worth facility, where the company plans to begin system testing, diagnostics validation and safety evaluations following regulatory review and site readiness preparations.


InvestorNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Expands withZeta.ai Roadmap With Multi-Agent AI and Computational Biology Tools

May 7, 2026Lantern Pharma (NASDAQ: LTRN), an AI-driven precision oncology company, unveiled the next phase of development for its withZeta. ai platform, including planned launches of ZetaSwarm(TM), an autonomous multi-agent AI research system, ZetaOmics(TM), a computational biology and multi-omic analytics toolkit, and new enterprise-grade capabilities designed to support institutional oncology research and drug discovery workflows.


Pipeline Maturity is Redefining Valuations in Biotech

May 7, 2026 The biotechnology industry is going through a transformation that is redefining how a company’s value is interpreted. While revenue has traditionally been highly associated with a company’s valuation, clinical-stage progression and a company’s probability of success are being increasingly factored into its valuation.


InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Signs LOI to License CardioDialysis Technology From Sigyn Therapeutics

May 7, 2026Oragenics (NYSE American: OGEN) and Sigyn Therapeutics Inc. (OTCQB: SIGY) announced the signing of a letter of intent under which Oragenics expects to obtain an exclusive license to develop and commercialize Sigyn’s CardioDialysis(TM) blood purification technology for traumatic brain injury and chronic neurodegenerative diseases, complementing Oragenics’ Phase IIa intranasal neurosteroid candidate ONP-002 in a proposed dual-modality approach targeting inflammation on both sides of the blood-brain barrier.


MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Evaluating Dividend Spin-Out of Acoustic Sciences Division Into API Media

May 7, 2026Datavault AI (NASDAQ: DVLT) announced that management has begun evaluating a potential dividend spin-out of its Acoustic Sciences division into a standalone public company proposed to be named API Media, with the reserved Nasdaq ticker symbol “ADIO,” as the company seeks to separate its acoustic technologies and live events operations from its AI-driven data monetization business. The proposed transaction remains subject to board approval, definitive agreements, regulatory approvals and other closing conditions.


AINewsBreaks – Nightfood Holdings (OTCQB: NGTF) Spotlighted in AINewsWire Coverage of Expanding Service Robotics Market

May 7, 2026Nightfood Holdings (OTCQB: NGTF) announced its inclusion in an editorial published by AINewsWire examining the accelerating adoption of service robotics across industries including healthcare, logistics and hospitality, highlighting the company’s focus on scalable AI-driven robotics systems and strategic collaborations as global demand for automation continues to expand. To view the full press release, visit https://ibn.


BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Expands Concierge Cardiology Footprint With Atelier Health Agreement

May 7, 2026HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care solutions, announced a commercial agreement with Beverly Hills-based concierge medical practice Atelier Health, expanding the company’s launch footprint into Southern California and completing its initial targeted markets alongside New York metro, Dallas and South Florida as it advances commercialization of its cable-free 3D ECG technology for remote cardiac monitoring and preventive cardiology. To view the full press release, visit https://ibn.